CLINICAL_TRIALS
trial_result
· 2021-04-01
Clinical Trial Update: PTI-125 for Mild-to-moderate Alzheimer's Disease Patients [Phase 2]
Summary
Phase 2 clinical trial for PTI-125 in mild-to-moderate Alzheimer's disease completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pain Therapeutics | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-04-01